Gemoscan Canada Inc.  

(Public, CVE:GES)   Watch this stock  
Find more results for GES
-0.0450 (-52.94%)
Dec 19 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.04 - 0.04
52 week 0.04 - 0.10
Open 0.04
Vol. 14,100.00
Mkt cap 3.23M
P/E     -
Div/yield     -
EPS -0.03
Shares 37.99M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -59.93% -47.81%
Operating margin -50.47% -36.22%
EBITD margin - -28.43%
Return on average assets -75.52% -119.67%
Return on average equity - -
Employees 13 -
CDP Score - -


5000 Dufferin St Unit D1
+1-416-6501200 (Phone)
+1-416-6505700 (Fax)

Website links


Gemoscan Canada, Inc. (Gemoscan) is engaged in the provision of products and solutions to the food intolerance market. Gemoscan develops, owns and markets food sensitivity and dietary management solutions for consumers, including the HEMOCODE Food Intolerance System and the MenuWise Food Intolerance Plan, personalized naturopathic nutritional programs. The Company operates in the global diet-related disorder market place. The Company commercializes a food intolerance management solution directly to consumers in partnership with retailers, and offers services available. Gemoscan solutions use its technology and services to simplify the identification and management of food sensitivities while providing ongoing consultation and recommendations for dietary change, including nutritional supplements.

Officers and directors

Brian Kalish President, Chief Executive Officer, Director
Age: 42
Stephen M. Gledhill Chief Financial Officer, Secretary
Age: 49
Kathleen E. Skerrett Director
Elisa Swern Director
James N. Jones Independent Director
Age: 62
Jack Steckel Independent Director
Scott E. Wilson Independent Director
Age: 42